Literature DB >> 12717619

Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women.

Cynthia T Stover1, Dawn K Smith, D Scott Schmid, Philip E Pellett, John A Stewart, Robert S Klein, Kenneth Mayer, David Vlahov, Paula Schuman, Michael J Cannon.   

Abstract

Viruses that can persist in the host are of special concern in immunocompromised populations. Among 871 human immunodeficiency virus (HIV)-infected and 439 high-risk HIV-uninfected women, seroprevalences of cytomegalovirus, hepatitis B virus, hepatitis C virus, and herpes simplex virus types 1 and 2 and prevalence of human papillomavirus DNA in cervicovaginal lavage fluids were all >50% and were 2-30 times higher than prevalences in the general population. Prevalences were highest among HIV-infected women, of whom 44.2% had >or=5 other infections, and were relatively high even among the youngest women (age 16-25 years). In multivariate analyses, viral infections were independently associated not only with behaviors such as injection drug use and commercial sex but also with low income, low levels of education, and black race. Disadvantaged women and women who engage in high-risk behaviors are more likely to be coinfected with HIV and other viruses and, thus, may be at high risk of serious disease sequelae.

Entities:  

Mesh:

Year:  2003        PMID: 12717619     DOI: 10.1086/374649

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.

Authors:  George J Xu; Tomasz Kula; Qikai Xu; Mamie Z Li; Suzanne D Vernon; Thumbi Ndung'u; Kiat Ruxrungtham; Jorge Sanchez; Christian Brander; Raymond T Chung; Kevin C O'Connor; Bruce Walker; H Benjamin Larman; Stephen J Elledge
Journal:  Science       Date:  2015-06-05       Impact factor: 47.728

Review 2.  Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Terri B Hyde; D Scott Schmid
Journal:  Rev Med Virol       Date:  2011-06-15       Impact factor: 6.989

3.  Addition of Acyclovir does not affect Adherence to HAART in HIV-1/ HSV-2 Co-Infected Women.

Authors:  Cynthia Eleanya; Allison Delong; Stacey Chapman; Ank Nijhawan; Jessica Ingersoll; Angela M Caliendo; Susan Cu-Uvin
Journal:  J AIDS Clin Res       Date:  2010-12-22

Review 4.  A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2.

Authors:  K J Looker; G P Garnett
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

Review 5.  Complex decisions in managing HIV infection during pregnancy.

Authors:  Mary A Vogler; Harjot Singh; Rodney Wright
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

Review 6.  Reframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients.

Authors:  Barbara Gerbert; Dale W Danley; Karen Herzig; Kathleen Clanon; Daniel Ciccarone; Paul Gilbert; Michael Allerton
Journal:  AIDS Patient Care STDS       Date:  2006-01       Impact factor: 5.078

7.  HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.

Authors:  Jason T Blackard; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Denise J Jamieson; Lytt Gardner; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

8.  Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.

Authors:  A Jewett; B D Smith; R S Garfein; J Cuevas-Mota; E H Teshale; C M Weinbaum
Journal:  J Clin Virol       Date:  2012-05-03       Impact factor: 3.168

9.  Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States.

Authors:  Irene Kuo; Carol E Golin; Jing Wang; Danielle F Haley; James Hughes; Sharon Mannheimer; Jessica Justman; Anne Rompalo; Paula M Frew; Adaora A Adimora; Lydia Soto-Torres; Sally Hodder
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

10.  Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women.

Authors:  Peter D Dryer; Berkeley N Limketkai; Christina M Martin; Gang Ma; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson; Jason T Blackard
Journal:  J Antimicrob Chemother       Date:  2009-09-18       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.